Author(s):
Astha, Monika Gupta, Anju Goyal, Neelam Jain, Somnath Bhinge, Rashmi Arora
Email(s):
anju_goyal2003@rediffmail..com , anju.anjugoyal.goyal@gmail.com
DOI:
10.52711/0974-360X.2025.00140 
Address:
Astha1, Monika Gupta2, Anju Goyal3*, Neelam Jain4, Somnath Bhinge5, Rashmi Arora6
1,6Chitkara College of Pharmacy, Chitkara University, Punjab, India
2A.S.B.A.S.J.S Memorial College Of Pharmacy, Bela, Punjab, India.
3University School of Pharmaceutical Sciences, Rayat-Bhara University, Kharar, Punjab, India.
4Deapartment of Pharmaceutical Education and Research, Faculty of Pharmaceutical Sciences, BPSMV, Khanpur Kalan, Sonepat, Haryana, India.
5Krishna Vishwa Vidyapeeth (Deemed To Be University), Krishna Institute of Pharmacy, Karad, Maharashtra, 415539, India.
*Corresponding Author
Published In:
Volume - 18,
Issue - 3,
Year - 2025
ABSTRACT:
Cancer encompasses various diseases marked by abnormal, uncontrolled cell growth that can invade healthy tissues, spread to other body parts, and remains a major global health concern. The present work involves the synthesis of novel coumarin derivatives and their preliminary in vitro biological evaluation as anticancer agents against MCF-7 breast cancer cell lines. The newly synthesized compounds were character on the basis of various spectral analytical techniques like IR and 1H-NMR. In vitro testing was conducted using the MTT assay protocol, with each derivative tested at four concentration levels: 10 µgmL-1, 20 µgmL-1, 40 µgmL-1, and 80 µg mL-1. The antiproliferative evaluation was done against breast cancer cell line. Compound 10 and Compound 1 were found the most potent compounds among the series against all the cell lines with IC50 values. Other molecules revealed good to moderate activity. This indicated that the molecules are safer for normal healthy cells.
Cite this article:
Astha, Monika Gupta, Anju Goyal, Neelam Jain, Somnath Bhinge, Rashmi Arora. Design, Synthesis and Characterization of Novel Coumarin Derivatives as Potential Human Epidermal Growth Receptor - 2 Inhibitors for their Anti-Breast Cancer Activity. Research Journal Pharmacy and Technology. 2025;18(3):957-9. doi: 10.52711/0974-360X.2025.00140
Cite(Electronic):
Astha, Monika Gupta, Anju Goyal, Neelam Jain, Somnath Bhinge, Rashmi Arora. Design, Synthesis and Characterization of Novel Coumarin Derivatives as Potential Human Epidermal Growth Receptor - 2 Inhibitors for their Anti-Breast Cancer Activity. Research Journal Pharmacy and Technology. 2025;18(3):957-9. doi: 10.52711/0974-360X.2025.00140 Available on: https://rjptonline.org/AbstractView.aspx?PID=2025-18-3-1
5. REFERENCES:
1. Arruebo, Manuel, et al. Assessment of the evolution of cancer treatment therapies. Cancers. 2011; 3(3): 3279-3330.
2. Bhatia, Rohit, Ravindra K. Rawal, et al. Coumarin hybrids: Promising scaffolds in the treatment of breast cancer. Mini Reviews in Medicinal Chemistry. 2019; 19(17): 1443-1458.
3. Bissell, Mina J, Derek Radisky et al. Putting tumours in context.Nature Reviews Cancer. 2001; 1(1): 46-54.
4. Bhardwaj, Priya, et al.Estrogens and breast cancer: Mechanisms involved in obesity-related development, growth and progression.The Journal of Steroid Biochemistry and Molecular Biology. 2019;189: 161-170.
5. Brueggemeier, Robert W, Jeanette A. Richards, et al. Aromatase and cyclooxygenases: enzymes in breast cancer. The Journal of Steroid Biochemistry and Molecular Biology. 2003; 86(3): 501-507.
6. Bollet, Marc A, et al. Tumor aromatase expression as a prognostic factor for local control in young breast cancer patients after breast-conserving treatment. Breast Cancer Research. 2009;11(1): 1-11.
7. Bhatnagar, Ajay S, et al. The discovery and mechanism of action of letrozole. Breast Cancer Research and Treatment. 2007; 85(3): 7-17.
8. BaLLazhI, LuLzImE, et al. Potential antiproliferative effect of isoxazolo-and Thiazolo coumarin derivatives on breast cancer mediated bone and lung metastases. Acta Pharmaceutica. 2015; 65(1): 53-63.
9. Burns, Katherine A, et al. Estrogen receptors and human disease: an update.Archives of Toxicology. 2012; 86(1): 1491-1504.
10. Chand, Karam, et al.Synthesis and antiproliferative and c-Src kinase inhibitory activities of cinnamoyl-and pyranochromen-2-one derivatives. Canadian Journal of Chemistry. 2013; 91(8): 741-754.
11. Duss, Stephan, et al. An oestrogen-dependent model of breast cancer created by transformation of normal human mammary epithelial cells.Breast Cancer Research. 2007; 9(1): 1-15.
12. Aggarwal, Sunaina, Anju Goyal, et al. Synthetic procedures and pharmacological activities of 1, 2, 4-oxadiazoles-a review. Research Journal of Pharmacy and Technology. 2020; 13(10): 5026-5033.
13. Drwal, Malgorzata N, et al. Protox: a web server for the in silico prediction of rodent oral toxicity.Nucleic Acids Research. 2014; 42(1): 53-58.
14. Esteller, Manel, et al. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene. 2002; 21(35): 5427-5440.
15. Ertl, Peter, Bernhard Rohde, et al. Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. Journal of Medicinal Chemistry. 2000; 43(20): 3714-3717.
16. Fares, Jawad, et al. Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduction and Targeted Therapy. 2020; 5(1) : 28.
17. Fan, Jiyu, Ailing Fu, et al. Progress in molecular docking. Quantitative Biology.2019; 7(5): 83-89.
18. Fayed, Eman A., et al. Design, synthesis, biological evaluation and molecular modeling of new coumarin derivatives as potent anticancer agents.Medicinal Chemistry Research. 2019; 28(1): 1284-1297.
19. Hapach, Lauren A, et al. Engineered models to parse apart the metastatic cascade. NPJ Precision Oncology. 2019; 3(1): 20.
20. Furrer, Daniela, et al. The human epidermal growth factor receptor 2 (HER2) as a prognostic and predictive biomarker: Molecular insights into HER2 activation and diagnostic implications. Cancer Prognosis. 2018; 5: 11